Lysine methyltransferase G9a is an important modulator of trained immunity.

Vera P Mourits Jelmer H van PuffelenBoris NovakovicMariolina BrunoAnaísa V FerreiraRob Jw ArtsLaszlo GrohTania O CrișanJelle ZwaagElisa JenthoMatthijs KoxPeter PickkersFrank L van de VeerdonkSebastian WeisEgbert OosterwijkSita H VermeulenMihai G NeteaLeo Ab Joosten

Published in: Clinical & translational immunology (2021)

Inhibition of G9a is important in the induction of trained immunity, and G9a may represent a novel therapeutic target in NMIBC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
resistance training
peritoneal dialysis
prognostic factors
body composition
patient reported outcomes
patient reported